Clinical Trial Update: Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy of the first-line B-RI regimen in treatment-naive Waldenström's macroglobulinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• B-RI

Snippet

Sponsor: Christian Buske | Conditions: Waldenstrom Macroglobulinemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING